HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro and in vivo evaluations of a radioiodinated thymidine phosphorylase inhibitor as a tumor diagnostic agent for angiogenic enzyme imaging.

AbstractINTRODUCTION:
The expression of thymidine phosphorylase (TP) is closely associated with angiogenesis, tumor invasiveness and activation of antitumor agents. We evaluated radioiodinated 5-iodo-6-[(2-iminoimidazolidinyl)methyl]uracil ([(125)I]IIMU) having high TP-inhibitory potency as the new radiotracer for SPECT targeting of TP expression in tumors.
METHODS:
The characteristics of the radioiodinated TP inhibitor IIMU were determined by evaluating the uptake by tumor cells in vitro and by biodistribution studies in vivo. The distribution of the radiotracer and the extent of TP-specific uptake by tumors were evaluated by a counting method in tumor-bearing mice.
RESULTS:
The in vitro uptake of radiolabeled IIMU by A431 cells along with high TP expressions was attributed to the binding of the radiotracer to its target enzyme, i.e., TP. In vivo distribution of the radiotracer in A431 tumor-bearing mice revealed tumor/blood and tumor/muscle activity uptake ratios of 36 and 106, respectively, at 3 h after the radiotracer injection. On using low TP-expressing tumors and TP blocking studies as controls, minor TP-specific accumulation of the radiotracer was detected in these studies.
CONCLUSION:
According to the binding of radioiodinated IIMU to the angiogenic enzyme TP, it can be concluded that radioiodinated IIMU might be suitable as a SPECT tracer for tumor imaging.
AuthorsHiromichi Akizawa, Songji Zhao, Masayuki Takahashi, Ken-ichi Nishijima, Yuji Kuge, Nagara Tamaki, Koh-ichi Seki, Kazue Ohkura
JournalNuclear medicine and biology (Nucl Med Biol) Vol. 37 Issue 4 Pg. 427-32 (May 2010) ISSN: 1872-9614 [Electronic] United States
PMID20447553 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright(c) 2010 Elsevier Inc. All rights reserved.
Chemical References
  • 5-iodo-6-((2-iminoimidazolidinyl)methyl)uracil
  • Enzyme Inhibitors
  • Iodine Radioisotopes
  • Uracil
  • Thymidine Phosphorylase
Topics
  • Animals
  • Biological Transport
  • Cell Line, Tumor
  • Enzyme Inhibitors (chemistry, metabolism, pharmacokinetics)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Iodine Radioisotopes
  • Mice
  • Neoplasms (blood supply, diagnostic imaging, metabolism, pathology)
  • Neovascularization, Pathologic (diagnostic imaging, enzymology)
  • Thymidine Phosphorylase (antagonists & inhibitors, metabolism)
  • Tomography, Emission-Computed, Single-Photon
  • Uracil (analogs & derivatives, chemistry, metabolism, pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: